N , N ‐Diarylsulfonamide Reduces Proinflammatory Cytokine Interleukin‐6 Levels in Cells through Nuclear Factor‐κB Regulation
ChemMedChem · 2024
DOI: 10.1002/cmdc.202300598 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, 2024. Verfasst von Dattatraya A Babar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Natural Products and Medicinal Chemistry, CSIR-Indian Institute of Chemical Technology, Hyderabad, India-, 500007. Hauptthemen laut MEDLINE: NF-kappa B, Interleukin-6, Sulfonamides, Lipopolysaccharides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Deshbhakt Anandrao Balwantrao Naik Arts and Science College, Chikhali, Sangli, INSA, Department of Science and Technology, Government of India.
Abstract (Originalsprache)
The arylsulfonamides were synthesized from aryl sulfonyl chloride and aromatic amines in dichloromethane in the presence of pyridine. The aryne chemistry was used to prepare diarylsulfonamide from arylsulfonamides and O ‐silylaryl triflate with CsF in acetonitrile at room temperature for 30 min. The synthesized compounds were evaluated for cytotoxicity followed by the cytokine/inflammatory marker's inhibition capability and its mechanism of action in RAW‐264.7 cells. Elevated interleukin‐6 (IL‐6) levels have been reported in inflammatory conditions and inflammation‐associated disorders. Hence, reducing the IL‐6 levels in inflammatory conditions can serve as an attractive therapeutic target in dealing the inflammation. Among 42 compounds, seven compounds showed significant inhibition of IL‐6 levels in lipopolysaccharide (LPS) challenged RAW‐264.7 cells at 12.5 μM concentration. Further, investigation revealed that the IC 50 value of these compounds for reducing IL‐6 levels was found to be in the range of 2.6 to 9.7 μM. The promising compounds 5y (IC 50 of 2.6 μM) and 5n (IC 50 of 4.1 μM) along with other derivatives fulfil drug‐likeness parameters laid down by Lipinski's rule of five. Further, RT‐qPCR and Western‐blot analysis revealed that treatment with 5n significantly reduced the expression of pro‐inflammatory, inflammatory and macrophage marker's expression (IL‐1β, CCL2, COX2 and CD68) compared to LPS control. The mechanistic evaluation showed that 5n exhibited anti‐inflammatory properties by modulating the nuclear factor‐κB (NF‐κB) activation. The identified compound can be a promising candidate for further discovery efforts to generate a preclinical candidate effective in inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Natural Products and Medicinal Chemistry, CSIR-Indian Institute of Chemical Technology, Hyderabad, India-, 500007.
- Academy of Scientific and Innovative Research, Ghaziabad, Uttar Pradesh, 201 002, India.
- Department of Applied Biology, CSIR-Indian Institute of Chemical Technology, Hyderabad, 500 007, India.
ORCID-Profile: Haridas B Rode
Förderung
- Deshbhakt Anandrao Balwantrao Naik Arts and Science College, Chikhali, Sangli
- INSA
- Department of Science and Technology, Government of India
- CSIR-IICT
- Indian National Science Academy
Zitieren
APA
Babar, D. A., Khansole, G., Kumar Singh, V., Shinde, A., Vaishnavi, K., Balaji, A. S., & Rode, H. B. (2024). N , N ‐Diarylsulfonamide Reduces Proinflammatory Cytokine Interleukin‐6 Levels in Cells through Nuclear Factor‐κB Regulation. ChemMedChem. https://doi.org/10.1002/cmdc.202300598
Vancouver
Babar DA, Khansole G, Kumar Singh V, Shinde A, Vaishnavi K, Balaji AS, et al. N , N ‐Diarylsulfonamide Reduces Proinflammatory Cytokine Interleukin‐6 Levels in Cells through Nuclear Factor‐κB Regulation. ChemMedChem. 2024. doi:10.1002/cmdc.202300598
BibTeX
@article{Babar2024,
author = {Babar, Dattatraya A and Khansole, Gopinath and Kumar Singh, Vishal and Shinde, Akash and Vaishnavi, Kambhampati and Balaji, Andugulapati Sai and Rode, Haridas B},
title = {N , N ‐Diarylsulfonamide Reduces Proinflammatory Cytokine Interleukin‐6 Levels in Cells through Nuclear Factor‐κB Regulation},
journal = {ChemMedChem},
year = {2024},
doi = {10.1002/cmdc.202300598}
}
EUVIMED